Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Gastrointestinal disease

Celiac Disease Market Growth Expected to Reach US$ 1,362.1 Million by 2034

The Celiac Disease Market is expected to witness significant growth in the coming years, with the market reaching a value of US$ 1,362.1 Million by 2034, showing a growth rate (CAGR) of 9.85% during 2023-2034. Enzyme supplements like lactase and alpha-galactosidase are being widely used to improve digestion and reduce symptoms of bloating and gas, further fueling market growth. Key players in the industry are investing heavily in exploring microbial therapies like fecal microbiota transplantation (FMT) and probiotics to alter the gut microbiome and alleviate inflammation in the intestine, which is driving market expansion. The adoption of gluten-detoxification therapies and the increasing use of non-invasive methods for diagnosing celiac disease using saliva are expected to propel market growth in the forecast period.

Exploring Effective Treatments for I.B.S.

Explore effective treatments for I.B.S. with insights from experts like Dr. Brian Lacy and Dr. William Chey. Learn about dietary modifications, medications, and the latest research findings to manage symptoms and improve quality of life.

Breath Analysis for Gut Issues

Learn about the potential of breath analysis in diagnosing gut health issues like IBS and SIBO. Owlstone Medical’s OMED Health offers at-home breath test kits for just £250, providing a non-invasive and affordable option for diagnosis and monitoring of gut-related problems.

Over 100 Passengers and Crew on Cunard Cruise Ship Queen Victoria Affected by Gastrointestinal Illness

Reports from the US Centers for Disease Control and Prevention have revealed that over 100 passengers and crew members on the Cunard cruise ship Queen Victoria have been affected by gastrointestinal illness during a three-week leg of a 107-night cruise….